Navigation Links
Pharmacyclics Reports Second Quarter 2014 Results
Date:7/31/2014

The enrollment target of this global study is 400 patients.

Marginal Zone Lymphoma (MZL)

  • PCYC-1121: Phase II study of IMBRUVICA in patients with R/R marginal zone lymphoma was initiated in the fourth quarter of 2013. This is a multi center, open-label, monotherapy study to evaluate the safety and efficacy of IMBRUVICA in patients with R/R marginal zone lymphoma. The primary endpoint of this study is overall response rate and the enrollment target of this study is 60 patients.
  • Waldenstrom's Macroglobulinemia (WM)

  • PCYC-1127: Phase III study of IMBRUVICA or placebo in combination with rituximab in patients with previously treated WM was initiated in the second quarter of 2014. This is a randomized, multi-center, double-blinded, placebo-controlled trial of IMBRUVICA.  The primary outcome measure of this study is PFS. The secondary outcome measures include ORR, time to next treatment, OS and number of participants with AEs as a measure of safety and tolerability within each treatment arm. The enrollment target of this study is 180 patients.
  • Multiple Myeloma (MM)

  • PCYC-1111: Phase II study of IMBRUVICA in patients with R/R multiple myeloma was initiated in the first quarter of 2012. This is a Phase II, multi-center, open-label trial designed to assess the safety and efficacy of IMBRUVICA as a single agent and in combination with dexamethasone in patients with R/R MM. At this time, an expansion of cohorts 1, 2 and 3 (420mg, 560mg with dexamethasone, and 840mg) is not planned due to the fact that the protocol-defined response rate was not achieved. The Company has expanded the fourth and final dosing cohort to 43 patients (840mg with dexamethasone) as it crossed a minimum pre-defined boundary of efficacy. The clinical development focus of IMBRUVICA in this indication will be in combination therapies.
  • PCYC-1119: Phase I/IIb study of IMBRUVICA in combination with carfilzomib in patients wi
    '/>"/>

  • SOURCE Pharmacyclics, Inc.
    Copyright©2014 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28

    Related medicine technology :

    1. Pharmacyclics Announces Date of Conference call to discuss Financial Results for Second Quarter of 2014
    2. Pharmacyclics Announces Data Presentations for Ibrutinib in B-Cell Malignancies
    3. WuXi PharmaTech to Partner with Pharmacyclics
    4. Pharmacyclics Reports Third Quarter 2013 Results
    5. Pharmacyclics Announces Date of Conference call to discuss Financial Results for Third Quarter Ended September 30, 2013
    6. Pharmacyclics Reports Second Quarter 2013 Results
    7. Pharmacyclics Announces Date of Financial Results for Second Quarter Ended June 30, 2013 and Conference Call
    8. Pharmacyclics Reports First Quarter 2013 Results
    9. Pharmacyclics Announces Date of Financial Results for Three Months Ended March 31, 2013 and Conference Call
    10. Pharmacyclics Triggers Fourth Milestone Payment for Enrollment of 5th Patient in Frontline Phase III CLL Study
    11. Pharmacyclics Announces Third Breakthrough Therapy Designation for Ibrutinib from the U.S. Food and Drug Administration
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:7/28/2015)... July 28, 2015 Research and Markets ... the "Global Hearing Aids Market 2015-2019" ... global hearing aids market to grow at a ... Factors such as changing demographics and ... growth. The market has witnessed immense technological advances. ...
    (Date:7/28/2015)... July 28, 2015  Leaf Healthcare releases white ... ulcers place on the healthcare system . ... to modern quality healthcare. Research by the U.S. ... Healthcare Research and Quality shows that pressure ulcers ... billion a year. The condition is both excruciatingly ...
    (Date:7/28/2015)... July 28, 2015   CSL Behring ... a Marketing Authorization Application (MAA) for the company,s ... IX with recombinant albumin (rIX-FP) for the prophylaxis ... Hemophilia B. Upon Swissmedic approval, rIX-FP will provide ... with dosing intervals up to 14 days. ...
    Breaking Medicine Technology:Global Hearing Aids Market 2015-2019 with G N Store Nord, Sonova Holdings & William Demant Dominating 2Impact of Pressure Ulcers on Patient Care: Leaf Healthcare Releases White Paper on the Healthcare Burden of Pressure Ulcers 2Impact of Pressure Ulcers on Patient Care: Leaf Healthcare Releases White Paper on the Healthcare Burden of Pressure Ulcers 3Swissmedic Accepts for Review CSL Behring's MAA for rIX-FP for Patients with Hemophilia B 2Swissmedic Accepts for Review CSL Behring's MAA for rIX-FP for Patients with Hemophilia B 3Swissmedic Accepts for Review CSL Behring's MAA for rIX-FP for Patients with Hemophilia B 4
    (Date:7/28/2015)... ... July 28, 2015 , ... ... biologics and biologic-device combination products for the treatment of bone disorders and conditions ... Patent No. 9,062,300 entitled "Fusion Proteins of Collagen Binding-Domain and Parathyroid Hormone". The ...
    (Date:7/28/2015)... , ... July 28, 2015 , ... ... to include a proprietary, web based clinical knowledge system, called “Referral Guidance.” ... based. It provides physicians who are anticipating making a subspecialty referral an ...
    (Date:7/28/2015)... ... July 28, 2015 , ... Every summer, the public is reminded ... caution when lighting fireworks in their own neighborhoods. Unfortunately, according to a recent report ... 3, 2015 USA Today article " Eye Injuries Caused by Fireworks Doubled in Last ...
    (Date:7/28/2015)... ... July 28, 2015 , ... ... (ACS-Heart Attack, Sudden Death, or Angina), many of whom are missed by conventional ... of individuals with active yet undetected sub-clinical disease, who are at risk of ...
    (Date:7/28/2015)... ... July 28, 2015 , ... There has been much discussion in ... bridges and railroads, often overlooked is the over 740,000 miles of municipal sewer ... into sewage treatment facilities. According to the American Society of Civil Engineers , ...
    Breaking Medicine News(10 mins):Health News:BiologicsMD, Inc. Announces Additional US Patent Issuance Covering Company’s Pipeline of Targeted Therapies 2Health News:Introducing Care to Care’s New Web Based “Referral Guidance” Program 2Health News:Carlsbad Ophthalmologist Discusses Doubling of Fireworks Eye Injuries in Three Year Span 2Health News:Carlsbad Ophthalmologist Discusses Doubling of Fireworks Eye Injuries in Three Year Span 3Health News:Utility of a novel coronary artery disease biomarker algorithm in modifying physician adherence to guideline therapy presented at 20th World Congress on Heart Disease 2Health News:With an Infrastructure Spending Bill on the Horizon, RestorationEze Discusses the Impact an Aging Sewer System is Having on Homeowners 2Health News:With an Infrastructure Spending Bill on the Horizon, RestorationEze Discusses the Impact an Aging Sewer System is Having on Homeowners 3
    ... will include lots of green vegetables, less of saturated fats// and ... the first of its kind in fifteen years. ... One cannot be very sure about Canadians following this advice seriously. ... the type of diet prescribed by the Food Guide may affect ...
    ... study conducted by the scientists at Western Infirmary Epilepsy ... as a single therapy. This study was published in ... study which had around six hundred participants who had ... last year to the drug levetiracetam or to controlled ...
    ... Advertising campaign pointing out the threat of losing vision ... in young population//. This was cited by the British ... National Institute of the Blind, losing vision is considered ... like stroke and lung cancer associated with it. Hence ...
    ... Clinical Pediatrics, it is reported that breast feeding mothers may ... care of, their children// may not be affected by vitamin ... team belonging to University of Michigan conducted a study among ... Twenty of the mothers were found to be deficient in ...
    ... Network (SIGN) has published a set of guidelines that ... complaints// like heart attacks and strokes in the next ... preventive treatment to about 500,000 people considered to be ... assessments for all over-40s especially those most at risk ...
    ... Thimphu: Sonam Choden, the mother of two-year-old Leki Dorji, never ... Christian Medical College in India's Tamil// Nadu state, which treated ... and also talk". ,Choden, an uneducated 23-year-old ... in her child was the happiest moment in her life, ...
    Cached Medicine News:Health News:A New Plan to Restrict Cardiovascular Diseases in Scotland 2
    Very concise book answering the question: "I've got a diagnosis, which drugs do I use?". All 15 chapters written by highly skilled US specialists...
    ... Guide for Nurses with Integrated Calculators, based ... is a remarkable advance in drug reference. ... Davis s Drug Guide (9th Edition) and ... based medications. This product merges many of ...
    Allows health professionals to answer consumers' questions regarding safety issues concerning possible drug-herb and drug-food interactions....
    ... DrDrugs®: Drug Guide ... with over 760 Integrated ... most comprehensive, up-to-date and ... built in drug dosing ...
    Medicine Products: